Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer
Abstract
N/A
World J Oncol. 2022;13(5):320-324
doi: https://doi.org/10.14740/wjon1494
World J Oncol. 2022;13(5):320-324
doi: https://doi.org/10.14740/wjon1494